A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)

Clinical trial NCT04830800 · COMPLETED

Trial details

NCT number: NCT04830800
Sponsor: Institute of Vaccines and Medical Biologicals, Vietnam
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Disease SARS Pneumonia Pneumonia, Viral COVID-19 Vaccine

Start date: 2021-03-10
Primary completion: 2021-06-06
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.